[go: up one dir, main page]

AU6458400A - Nucleic acid, polypeptides, assays, therapeutic methods and means - Google Patents

Nucleic acid, polypeptides, assays, therapeutic methods and means

Info

Publication number
AU6458400A
AU6458400A AU64584/00A AU6458400A AU6458400A AU 6458400 A AU6458400 A AU 6458400A AU 64584/00 A AU64584/00 A AU 64584/00A AU 6458400 A AU6458400 A AU 6458400A AU 6458400 A AU6458400 A AU 6458400A
Authority
AU
Australia
Prior art keywords
polypeptides
assays
nucleic acid
therapeutic methods
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU64584/00A
Inventor
Simon Davis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Publication of AU6458400A publication Critical patent/AU6458400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70532—B7 molecules, e.g. CD80, CD86
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU64584/00A 1999-08-11 2000-08-10 Nucleic acid, polypeptides, assays, therapeutic methods and means Abandoned AU6458400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14840299P 1999-08-11 1999-08-11
US60148402 1999-08-11
PCT/GB2000/003079 WO2001012658A2 (en) 1999-08-11 2000-08-10 Human icos ligand and application thereof

Publications (1)

Publication Number Publication Date
AU6458400A true AU6458400A (en) 2001-03-13

Family

ID=22525622

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64584/00A Abandoned AU6458400A (en) 1999-08-11 2000-08-10 Nucleic acid, polypeptides, assays, therapeutic methods and means

Country Status (2)

Country Link
AU (1) AU6458400A (en)
WO (1) WO2001012658A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3521382B2 (en) 1997-02-27 2004-04-19 日本たばこ産業株式会社 Cell surface molecules that mediate cell-cell adhesion and signal transduction
US7112655B1 (en) 1997-02-27 2006-09-26 Japan Tobacco, Inc. JTT-1 protein and methods of inhibiting lymphocyte activation
EP2332978B1 (en) 1999-02-03 2014-04-02 Amgen, Inc Novel polypeptides involved in immune response
US7708993B2 (en) 1999-02-03 2010-05-04 Amgen Inc. Polypeptides involved in immune response
US7435796B1 (en) 1999-02-03 2008-10-14 Amgen Inc. Antibodies which bind B7RP1
US8624010B1 (en) 1999-02-03 2014-01-07 Steven K. Yoshinaga Nucleic acids encoding B7RP1
JP3871503B2 (en) 1999-08-30 2007-01-24 日本たばこ産業株式会社 Immune disease treatment
JP4210454B2 (en) * 2001-03-27 2009-01-21 日本たばこ産業株式会社 Inflammatory bowel disease treatment
JP3597140B2 (en) 2000-05-18 2004-12-02 日本たばこ産業株式会社 Human monoclonal antibody against costimulatory molecule AILIM and pharmaceutical use thereof
JP4212278B2 (en) 2001-03-01 2009-01-21 日本たばこ産業株式会社 Graft rejection inhibitor
PH12022550138A1 (en) 2013-03-13 2023-03-06 Amgen Inc Proteins specific for baff and b7rp1 and uses thereof
US9458246B2 (en) 2013-03-13 2016-10-04 Amgen Inc. Proteins specific for BAFF and B7RP1
WO2024061930A1 (en) * 2022-09-22 2024-03-28 Institut National de la Santé et de la Recherche Médicale New method to treat and diagnose peripheral t-cell lymphoma (ptcl)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995003408A1 (en) * 1993-07-26 1995-02-02 Dana-Farber Cancer Institute B7-2: ctl a4/cd 28 counter receptor
AU752433B2 (en) * 1997-09-23 2002-09-19 Bundesrepublik Deutschland letzvertreten durch Den Direktor des Robert-Koch-Instituts Costimulating T-cell polypeptide, monoclonal antibodies, their preparation and use
EP2332978B1 (en) * 1999-02-03 2014-04-02 Amgen, Inc Novel polypeptides involved in immune response

Also Published As

Publication number Publication date
WO2001012658A3 (en) 2001-08-30
WO2001012658A2 (en) 2001-02-22

Similar Documents

Publication Publication Date Title
AU6629200A (en) Alpha-helical peptide nucleic acid alpha-pna
AU4975300A (en) Dna melting curve analysis
AU1339701A (en) Anti-cancer nucleic acid and protein targets
AU1191001A (en) Plasminogen-like polynucleotides, polypeptides, and antibodies
AU6045900A (en) Interaction-activated proteins
AU7337400A (en) B7-like polynucleotides, polypeptides, and antibodies
AU6458400A (en) Nucleic acid, polypeptides, assays, therapeutic methods and means
AU3178200A (en) Genetic analysis
AU1582401A (en) Uteroglobin-like polynucleotides, polypeptides, and antibodies
AU7335400A (en) Attractin-like polynucleotides, polypeptides, and antibodies
AU5245900A (en) Novel protein and dna thereof
GB9714971D0 (en) Assays,therapeutic methods and means
GB0007933D0 (en) Assays,methods and means
AU1891301A (en) Novel polypeptide and dna thereof
AU3511100A (en) Novel nucleic acids and polypeptides
AU7987800A (en) Anti-aging nucleic acid and protein targets
AU2003234274A1 (en) D1-1 nucleic acids, polypeptides and related methods
AU2002365189A1 (en) P85-alpha nucleic acids, polypeptides and related methods
AU2225401A (en) Novel protein and dna thereof
AU3440700A (en) Assays, methods and means
AU1690200A (en) Novel protein and dna thereof
GB9726575D0 (en) Nucleic acid, polypeptides, assays, therapeutic methods and means
AU2059500A (en) Huhdgfh nucleic acids, polypeptides, methods and uses thereof
AU2813700A (en) Protein assay
AU1134601A (en) Assay method

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase